About
Hypervision Surgical is a medical technology company founded in 2020 as a spin-out from King's College London. Based at the London Institute For Healthcare Engineering, the company specializes in advanced surgical imaging and data analytics. Its core offering is an AI-powered hyperspectral imaging platform that provides real-time tissue characterization during surgery. This technology allows surgeons to visualize physiological tissue properties without the use of contrast agents, enhancing precision and safety in surgical procedures. The platform is particularly beneficial in complex surgeries, such as brain tumor removal, where distinguishing between healthy and unhealthy tissue is crucial. Hypervision Surgical aims to improve intraoperative decision-making and reduce reliance on subjective assessments. The company targets healthcare providers and surgical teams globally, integrating its technology into existing surgical workflows to support minimally invasive procedures. With significant funding and recognition in the digital surgery community, Hypervision Surgical is positioned to make a meaningful impact on surgical outcomes and patient safety.
Technologies
Keywords
Company Information
-
Employees 21
-
Founded 2021
-
Total Funding $8056945
Location
85 Great Portland Street, London, England, United Kingdom, W1W 7LT
